Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 3
This trial is comparing atezolizumab and cabozantinib with docetaxel for people with non small cell lung cancer.
It is for people whose cancer has spread elsewhere in the body. This is advanced lung cancer.
Recruitment start: 1 December 2020
Recruitment end: 11 October 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Tom Newsom-Davis
Chugai Pharmaceutical Co Ltd
Exelixis
F. Hoffmann La Roche
Genentech Inc
Ipsen Pharma SAS
Takeda Pharmaceutical Co Ltd
Last reviewed: 1 November 2021
CRUK internal database number: 17226
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
